Phase I and pharmacokinetic study of DX-8951f (exatecan mesylate), a hexacyclic camptothecin, on a daily-times-five schedule in patients with advanced leukemia (Q44061906)
Jump to navigation
Jump to search
scientific article published in July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of DX-8951f (exatecan mesylate), a hexacyclic camptothecin, on a daily-times-five schedule in patients with advanced leukemia |
scientific article published in July 2002 |
Statements
1 reference
Phase I and pharmacokinetic study of DX-8951f (exatecan mesylate), a hexacyclic camptothecin, on a daily-times-five schedule in patients with advanced leukemia (English)
1 reference
Hagop M Kantarjian
1 reference
Guillermo Garcia-Manero
1 reference
Jorge E Cortes
1 reference
Francis J Giles
1 reference
Stephan Faderl
1 reference
Deborah A Thomas
1 reference
Sima Jeha
1 reference
Robert L De Jager
1 reference
1 July 2002
1 reference
1 reference
8
1 reference
7
1 reference
2134-2141
1 reference
Identifiers
1 reference